title: Reply: A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization.
authors.affiliation: University Medical Center Utrecht Heidelberglaan 100 3584 CX Utrecht, The Netherlands. E-mail: m.lam@umcutrecht.nl.
authors.forename: Marnix G E H
authors.initials: MG
authors.lastname: Lam
authors.forename: Maurits
authors.initials: M
authors.lastname: Wondergem
authors.forename: Mattijs
authors.initials: M
authors.lastname: Elschot
authors.forename: Maarten L J
authors.initials: ML
authors.lastname: Smits
mesh_terms: D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism* / Q000528:radiation effects*; D008297:Male; D008863:Microspheres; D012117:Resins, Synthetic / Q000737:chemistry*; D013668:Technetium Tc 99m Aggregated Albumin
chemical_list: D012117:Resins, Synthetic; D013668:Technetium Tc 99m Aggregated Albumin